Atlas Trials

Study of Hsp90 Inhibitor AUY922 for the Treatment of Patients With Refractory Gastrointestinal Stromal Tumor

Clinical trial NCT01404650 · COMPLETED

Trial details

NCT number
NCT01404650
Sponsor
SCRI Development Innovations, LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastrointestinal Stromal Tumor
Start date
2011-12-01
Primary completion
2015-02-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.